Program-2024

The 2024 Workshop Program is under development. Please see a sample of the 2023 Workshop Program below.
Program is subject to change. 

PRE-RECORDED LECTURES

Novel Trial Designs
James Doroshow, NCI Division of Cancer Treatment and Diagnosis, Bethesda, Maryland*
*Pre-recorded lecture only, will not be attending onsite


Leveraging Large Datasets in Clinical Trial Design 
Thomas Braun, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan

Workshop Pretest

Completed online between Saturday, July 22 and Sunday, July 23

SUNDAY, JULY 23

Registration
1:30 pm-5:30 pm

Faculty Meeting
4:30 pm-5:15 pm

Welcome/Overview
5:30 pm-5:45 pm
Manuel Hidalgo, Weill Cornell Medicine, New York Presbyterian Hospital, New York, New York
Jamie Von Roenn, American Society of Clinical Oncology, Alexandria, Virginia
Margaret Foti, American Association for Cancer Research, Philadelphia, Pennsylvania

Opening Keynote Lecture
Session Chair: Manuel Hidalgo, Weill Cornell Medicine, New York Presbyterian Hospital, New York, New York
5:45 pm-6:30 pm

  • Career Development Opportunities: The Government Can Help
    Oliver Bogler, National Cancer Institute, Rockville, Maryland

Dinner
6:30 pm-7:15 pm

Protocol Development Group Session
7:30 pm-9:00 pm

MONDAY, JULY 24

Breakfast
7:00 am-8:00 am

Lecture Session 1
Session Chair: Julie M. Vose, University of Nebraska Medical Center, Omaha, Nebraska
8:00 am-10:00 am

  • Clinical Trial Design: Asking Important Questions that Impact Our Patients
    Julie M. Vose, University of Nebraska Medical Center, Omaha, Nebraska
  • Answering Important Questions: From Hypothesis to Analysis
    Thomas M. Braun, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan
  • Phase I Trial Questions
    Manuel Hidalgo, Weill Cornell Medicine, New York Presbyterian Hospital, New York, New York
  • Phase I Trial Designs
    Nolan A. Wages, Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia

Questions / Panel Discussion

Break
10:00 am-10:20 am

Lecture Session 2
Session Chair: Maha Hussain, Northwestern University Feinberg School of Medicine, Chicago, Illinois
10:20 am-12:00 pm

  • Phase II Trial Questions/Objectives
    Maha Hussain, Northwestern University Feinberg School of Medicine, Chicago, Illinois
  • Phase II Trial Designs
    Sean Devlin, Memorial Sloan Kettering Cancer Center, New York, New York        
  • Drug Combination Trials
    Manish Shah, Weill Cornell Medical College, New York, New York
  • Multimodality Trials
    Karyn Goodman, Icahn School of Medicine at Mount Sinai, New York, New York

Questions / Panel Discussion

Lunch
12:00 pm-1:30 pm

Protocol Development Group 2
1:30 pm-4:00 pm

Independent Study Time
4:00 pm-7:00 pm

Personalized Mentoring Session (Biostatisticians and Patient Advocates; prescheduled appointments)
4:30 pm-6:30 pm

ASSIGNMENT DUE: PROTOCOL TEMPLATE
7:00 pm

Dinner
7:00 pm-9:00 pm

TUESDAY, JULY 25

Breakfast
7:30 am-8:30 am

Lecture Session 3
Session Chair: Wendy B. London, Boston Children’s Hospital/Dana-Farber Cancer Institute Boston, Massachusetts
8:30 am-10:00 am

  • Feasibility and Reproducibility in Biomarker Studies
    Kurt A. Schalper, Yale University, New Haven, Connecticut
  • Incorporation of Biological Correlative Studies into Early Clinical Trials
    Taofeek K. Owonikoko, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
  • Statistical Aspects of Correlative Studies
    Wendy B. London, Boston Children’s Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts

Questions / Panel Discussion

Break
10:00 am-10:30 am

Lecture Session 4
Session Chair: Ezra Cohen, Tempus Labs, La Jolla, California
10:30 am-12:00 pm

  • Imaging in the Era of Targeted Therapy and Immunotherapy
    Thomas E. Yankeelov, The University of Texas, Austin, Texas
  • Special Considerations in the Design of Immunotherapy Studies
    Ezra Cohen, Tempus Labs, La Jolla, California
  • Barriers to Accrual and How to Overcome Them
    Ruth O’Regan, University of Rochester, Rochester, New York

Questions / Panel Discussion

Lunch
12:00 pm-12:45 pm

Protocol Development Group Session 3
12:45 pm-3:45 pm

Break
3:45 pm-4:00 pm

Personalized Mentoring Session: Protocol Related Questions
4:00 pm-6:00 pm
Room locations noted on signup sheets
(Signup sheets will be available during the morning break.)

Independent Study Time
3:45 pm-7:00 pm
Pizza and salads available from 5:00 pm-7:00 pm

ASSIGNMENT DUE: STATISTICAL DESIGN
7:00 pm

WEDNESDAY, JULY 26

Breakfast
7:00 am-8:00 am

Small Group Discussion Sessions 1-3
8:00 am-9:00 am

  • Elements of Artificial Intelligence
    Thomas E. Yankeelov, The University of Texas, Austin, Texas
    Carole Baas, NCI Physical Sciences in Oncology Network, Southlake, Texas
  • Symptom Management, Patient Reported Outcomes, and Quality of Life
    Tanya Wildes, Univeristy of Nebraska Medical Center, Omaha, Nebraska
    Shing Lee, Columbia University, New York, New York
    Jill Feldman, EGFResiters, Evanston, Illinois
  • Phase III Trials
    Lindsay Renfro, University of Southern California, Los Angeles, California
    Elizabeth Plimack, Fox Chase Cancer Center, Philadelphia, Pennsylvania
    Josh Mailman, NorCal CarciNET Community, Oakland, California

Break
9:00 am-9:15 am

Small Group Discussion Sessions 4-6
9:15 am-10:15 am

  • Navigating the National Clinical Trials Network
    Colin Weekes, Massachusetts General Hospital, Boston, Massachusetts
    Vijaya Bhatt, University of Nebraska Medical Center, Omaha, Nebraska
  • Incorporation of Digital Health and PROs
    Adam Dicker, Thomas Jefferson University Kimmel Cancer Center, Philadelphia, Pennsylvania
    Sujata Patil, The Cleveland Clinic, Cleveland, Ohio      
    Josh Mailman, NorCal CarciNET Community, Oakland, California
  • Laboratory Correlates
    Ruth O’Regan, University of Rochester, Rochester, New York
    Kurt A. Schalper, Yale University, New Haven, Connecticut

Break / Group Photo
10:15 am-10:45 am

Small Group Discussion Sessions 7-9
10:45 am-11:45 am

  • Defining, Identifying, and Knowing Your Trial’s Clinical Endpoints
    John Byrd, University of Cincinnati College of Medicine, Cincinnati, Ohio
    Chen Hu, Johns Hopkins University, Baltimore, Maryland
    Sanford Jeames, PCORI/Huston-Tillotson University, Austin, Texas
  • First in Human Trials: Understanding the Regulatory Process
    Franklin Smith, Medpace, Cincinnatti, Ohio
    Douglas Yee, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota
  • Large-Scale Genomic Analysis: Bench to Bedside
    Manish Shah, Weill Cornell Medical College, New York, New York
    Manju George, Colontown, Crowdsville, Maryland

Lunch
11:45 am-12:30 pm

Protocol Development Group Session 4
12:30 pm-2:30 pm

Independent Study Time/Dinner on Own
2:30 pm-7:00 pm

ASSIGNMENT DUE: PROTOCOL DRAFTS
7:00 pm

THURSDAY, JULY 27

Breakfast
7:00 am-8:00 am

Lecture Session 5
Session Chair: Manish A. Shah, Weill Cornell Medical College, New York, New York
8:00 am-9:40 am

  • You’re in Charge: Investigator Responsibilities
    Manish A. Shah, Weill Cornell Medical College, New York, New York
  • How to Pay for Your Trial
    Douglas Yee, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota
  • Everything You Need to Know About Clinical Trial Ethics and Informed Consent
    Laura C. Michaelis, Medical College of Wisconsin, Milwaukee, Wisconsin
    Diana T. Chingos, DTC Consulting, Los Angeles, California
  • Community Engagement
    Sanford Jeames, PCORI/Huston-Tillotson University, Austin, Texas

Questions / Panel Discussion

Break
9:40 am-9:55 am

Lecture Session 6
Session Chair: Mark Krailo, University of Southern California, Los Angeles, California
9:55 am-11:35 am

  • Data Collection: It’s All In the Data
    Mark Krailo, University of Southern California, Los Angeles, California
  • Inclusivity in Clinical Trials
    Colin Weekes, Massachusetts General Hospital, Boston, Massachusetts
    Everett E. Dodson, Georgetown Lombardi Comprehensive Cancer Center (Retired), Washington DC

Questions / Panel Discussion

Break
11:35 am-11:45 am

Keynote Lecture
Session Chair: Julie M. Vose, University of Nebraska Medical Center, Omaha, Nebraska
11:45 am-12:35 pm

  • Patricia M. LoRusso, Yale Cancer Center, New Haven, Connecticut

Lunch
12:35 pm-1:30 pm

Protocol Development Group Session 5
1:30 pm-3:00 pm

Independent Study Time/Dinner on Own
3:00 pm-7:00 pm

Personalized Mentoring Session
3:30 pm-5:00 pm
Room locations noted on signup sheets
(Signup sheets will be available during the morning breaks.)

Optional Networking Session: Women in Hematology/Oncology
5:15 pm-6:15 pm

ASSIGNMENT DUE: INFORMED CONSENT DOCUMENTS
7:00 pm

FRIDAY, JULY 28

Breakfast
7:00 am-8:30 am

Faculty Meeting (Faculty Only)
7:30 am-8:30 am

Optional Career Sessions
(Exact topics to be determined based on accepted applicant interests, topics shown below are examples from past Workshops)
8:30 am-9:30 am

  • Collaborating and Networking
    Maura Dickler, Genentech, New York, New York
    Andrew M. Lowy, University of California, San Diego, San Diego, California
    Nathalie McKenzie, AdventHealth Cancer Institute, Orlando, Florida
  • Work-Life Balance
    Jeff Bogart, State University of New York, Syracuse, New York
    Tari King, Dana-Farber Cancer Institute/Brigham and Women’s Cancer, Boston, Massachusetts
    Franklin O. Smith, Medpace, Cincinnati, Ohio
  • Career Transition and Advancement Tips
    Ezra Cohen, Tempus Labs, La Jolla, California
    Taofeek K. Owonikoko, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
    Elizabeth Plimack, Fox Chase Cancer Center, Philadelphia, Pennsylvania

Break
9:30 am-9:45 am

Lecture Session 7
Session Chair: Alex A. Adjei, Cleveland Clinic, Cleveland, Ohio
9:45 am-11:10 am

  • Successful Grantsmanship
    Alex A. Adjei, Cleveland Clinic, Cleveland, Ohio
  • Reporting and Presenting Results
    Shing Lee, Columbia University, New York, New York
    Tari King, Dana-Farber Cancer Institute/Brigham and Women’s Cancer Center, Boston, Massachusetts

Questions / Panel Discussion

Break
11:10 am-11:20 pm

Protocol Development Group Session 6
11:20 am-1:00 pm

Lunch (Boxed)
1:00 pm-1:30 pm

Administration of Post-test
1:30 pm-2:30 pm

Independent Study Time
2:30 pm-7:00 pm

ASSIGNMENT DUE: FINAL PROTOCOLS, INFORMED CONSENT FORMS, and ALL WORKSHOP EVALUATIONS
7:00 pm

Closing Reception / Banquet / Dance
7:00 pm-11:00 pm

SATURDAY, JULY 29

Departure (on own)